Evidence map›Paper›PMID 25505382›Full record

ArticleFrontiers in cellular neuroscience2014

Pannexin 2 protein expression is not restricted to the CNS.

Maxence Le Vasseur, Jonathan Lelowski, John F Bechberger, Wun-Chey Sin, Christian C Naus

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Pannexins in the vasculature.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  4. Review
  5. Pannexin channels in inflammation and tumorigenesis.Frontiers in cell and developmental biology · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Structure-Based Design and Synthesis of StapledJournal of medicinal chemistry · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Pannexin1 channels-a potential therapeutic target in inflammation.Frontiers in cell and developmental biology · 2022
    Review
  17. Review
  18. ATP transporters in the joints.Purinergic signalling · 2021
    Review
  19. On the molecular nature of large-pore channels.Journal of molecular biology · 2021
    Review
  20. Double deletion of Panx1 and Panx3 affects skin and bone but not hearing.Journal of molecular medicine (Berlin, Germany) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maxence Le VasseurDepartment of Cellular and Physiological Sciences, The Life Science Institute, University of British Columbia Vancouver, BC, Canada.
Jonathan LelowskiDepartment of Cellular and Physiological Sciences, The Life Science Institute, University of British Columbia Vancouver, BC, Canada.
John F BechbergerDepartment of Cellular and Physiological Sciences, The Life Science Institute, University of British Columbia Vancouver, BC, Canada.
Wun-Chey SinDepartment of Cellular and Physiological Sciences, The Life Science Institute, University of British Columbia Vancouver, BC, Canada.
Christian C NausDepartment of Cellular and Physiological Sciences, The Life Science Institute, University of British Columbia Vancouver, BC, Canada.
University of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pannexins (Panx) are proteins homologous to the invertebrate gap junction proteins called innexins (Inx) and are traditionally described as transmembrane channels connecting the intracellular and extracellular compartments. Three distinct Panx paralogs (Panx1, Panx2 and Panx3) have been identified in vertebrates but previous reports on Panx expression and functionality focused primarily on Panx1 and Panx3 proteins. Several gene expression studies reported that Panx2 transcript is largely restricted to the central nervous system (CNS) hence suggesting that Panx2 might serve an important role in the CNS. However, the lack of suitable antibodies prevented the creation of a comprehensive map of Panx2 protein expression and Panx2 protein localization profile is currently mostly inferred from the distribution of its transcript. In this study, we characterized novel commercial monoclonal antibodies and surveyed Panx2 expression and distribution at the mRNA and protein level by real-time qPCR, Western blotting and immunofluorescence. Panx2 protein levels were readily detected in every tissue examined, even when transcriptional analysis predicted very low Panx2 protein expression. Furthermore, our results indicate that Panx2 transcriptional activity is a poor predictor of Panx2 protein abundance and does not correlate with Panx2 protein levels. Despite showing disproportionately high transcript levels, the CNS expressed less Panx2 protein than any other tissues analyzed. Additionally, we showed that Panx2 protein does not localize at the plasma membrane like other gap junction proteins but remains confined within cytoplasmic compartments. Overall, our results demonstrate that the endogenous expression of Panx2 protein is not restricted to the CNS and is more ubiquitous than initially predicted.

Indexed as

central nervous system (CNS)gap junctiongene transcriptionmousemRNApannexin 2protein distributionprotein expression

Identifiers

PMID25505382
PMCPMC4243559
OpenAlexW2022134062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.